Brown V, Sitzia J, Richardson A, Hughes J, Hannon H, Oakley C
Research and Development Department, Worthing and Southlands Hospitals NHS Trust, Lyndhurst Road, Worthing, West Sussex BN11 2DH, UK.
Int J Nurs Stud. 2001 Oct;38(5):497-510. doi: 10.1016/s0020-7489(00)00106-1.
The management of symptoms experienced by patients receiving cytotoxic chemotherapy influences quality of life during treatment. Symptom management may be improved through a structured approach to symptom assessment. This paper describes the development of the Chemotherapy Symptom Assessment Scale (C-SAS), a 24-item scale designed for the routine assessment of symptoms experienced by patients receiving cytotoxic chemotherapy. The scale development process focused both upon the psychometric properties and the clinical usefulness of the scale. Patients and health professionals played a significant role in item selection and scale design in order to maximise the clinical utility of the C-SAS.
接受细胞毒性化疗的患者所经历症状的管理会影响治疗期间的生活质量。通过结构化的症状评估方法可改善症状管理。本文描述了化疗症状评估量表(C-SAS)的开发过程,这是一个包含24个条目的量表,旨在对接受细胞毒性化疗的患者所经历的症状进行常规评估。量表开发过程既注重量表的心理测量特性,也注重其临床实用性。患者和卫生专业人员在条目选择和量表设计中发挥了重要作用,以最大限度地提高C-SAS的临床效用。